found that both UC and CD patients with DM2 presented a reduced risk of surgery when treated with GLP-1 RAs compared to other hypoglycemic agents ( With regard to safety concerns, the most prevalent adverse effects associated with GLP-1 RAs are gastrointestinal, such as bloating, dyspepsia, nausea, vomiting, diarrhea and constipation (108)
Why was my GLP-1 denied even though its FDA-approved
Potentially life-threatening
In the aesthetic and fitness definition phase, patients arent looking to lose a dramatic amount of weight
At this stage, asking "does GHK-Cu need refrigeration" isn't just a good idea
Patients should understand that individual responses may vary and that lack of response should prompt reassessment of the treatment approach rather than unlimited dose escalation